BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 17547583)

  • 1. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance.
    Burdick KE; Funke B; Goldberg JF; Bates JA; Jaeger J; Kucherlapati R; Malhotra AK
    Bipolar Disord; 2007 Jun; 9(4):370-6. PubMed ID: 17547583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
    Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
    Minzenberg MJ; Xu K; Mitropoulou V; Harvey PD; Finch T; Flory JD; New AS; Goldman D; Siever LJ
    Psychiatr Genet; 2006 Jun; 16(3):117-24. PubMed ID: 16691129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder.
    Soeiro-de-Souza MG; Machado-Vieira R; Soares Bio D; Do Prado CM; Moreno RA
    Bipolar Disord; 2012 Aug; 14(5):554-64. PubMed ID: 22713126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.
    Goldberg TE; Egan MF; Gscheidle T; Coppola R; Weickert T; Kolachana BS; Goldman D; Weinberger DR
    Arch Gen Psychiatry; 2003 Sep; 60(9):889-96. PubMed ID: 12963670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
    Bosia M; Bechi M; Marino E; Anselmetti S; Poletti S; Cocchi F; Smeraldi E; Cavallaro R
    Neurosci Lett; 2007 May; 417(3):271-4. PubMed ID: 17383818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.
    Ohnishi T; Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Iida H; Noguchi H; Nakabayashi T; Hori H; Ohmori M; Tsukue R; Anami K; Hirabayashi N; Harada S; Arima K; Saitoh O; Kunugi H
    Brain; 2006 Feb; 129(Pt 2):399-410. PubMed ID: 16330500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder.
    Lee SY; Chen SL; Chen SH; Huang SY; Tzeng NS; Chang YH; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    World J Biol Psychiatry; 2011 Aug; 12(5):385-91. PubMed ID: 20698735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMT Val 158 Met polymorphism is associated with cognitive flexibility in a signal discrimination task in schizophrenia.
    Neuhaus AH; Opgen-Rhein C; Urbanek C; Hahn E; Ta TM; Seidelsohn M; Strathmann S; Kley F; Wieseke N; Sander T; Dettling M
    Pharmacopsychiatry; 2009 Jul; 42(4):141-4. PubMed ID: 19585392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives.
    Golimbet V; Gritsenko I; Alfimova M; Lebedeva I; Lezheiko T; Abramova L; Kaleda V; Ebstein R
    World J Biol Psychiatry; 2006; 7(4):238-45. PubMed ID: 17071544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in COMT and neurocognitive impairment in families of patients with schizophrenia.
    Liao SY; Lin SH; Liu CM; Hsieh MH; Hwang TJ; Liu SK; Guo SC; Hwu HG; Chen WJ
    Genes Brain Behav; 2009 Mar; 8(2):228-37. PubMed ID: 19077118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study.
    Massat I; Souery D; Del-Favero J; Nothen M; Blackwood D; Muir W; Kaneva R; Serretti A; Lorenzi C; Rietschel M; Milanova V; Papadimitriou GN; Dikeos D; Van Broekhoven C; Mendlewicz J
    Mol Psychiatry; 2005 Jun; 10(6):598-605. PubMed ID: 15583702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia.
    Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D
    Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.
    Tunbridge E; Burnet PW; Sodhi MS; Harrison PJ
    Synapse; 2004 Feb; 51(2):112-8. PubMed ID: 14618678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory gating deficit is associated with catechol-O-methyltransferase polymorphisms in bipolar disorder.
    Ancín I; Cabranes JA; Vázquez-Álvarez B; Santos JL; Sánchez-Morla E; García-Jiménez MÁ; Fernández C; Barabash A
    World J Biol Psychiatry; 2011 Aug; 12(5):376-84. PubMed ID: 21595525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of bipolar mania is associated with catechol-O-methyltransferase Val(108/158)Met polymorphism.
    Benedetti F; Dallaspezia S; Locatelli C; Radaelli D; Poletti S; Lorenzi C; Pirovano A; Colombo C; Smeraldi E
    J Affect Disord; 2011 Jul; 132(1-2):293-6. PubMed ID: 21397335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.
    Sazci A; Ergul E; Kucukali I; Kilic G; Kaya G; Kara I
    Brain Res Mol Brain Res; 2004 Dec; 132(1):51-6. PubMed ID: 15548428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.